JPH0359735B2 - - Google Patents
Info
- Publication number
- JPH0359735B2 JPH0359735B2 JP58205527A JP20552783A JPH0359735B2 JP H0359735 B2 JPH0359735 B2 JP H0359735B2 JP 58205527 A JP58205527 A JP 58205527A JP 20552783 A JP20552783 A JP 20552783A JP H0359735 B2 JPH0359735 B2 JP H0359735B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- protein
- condensate
- amino acid
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims description 36
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 229940024606 amino acid Drugs 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 150000005846 sugar alcohols Polymers 0.000 claims description 15
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 10
- 239000007764 o/w emulsion Substances 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229960003136 leucine Drugs 0.000 claims description 6
- 239000004395 L-leucine Substances 0.000 claims description 4
- 235000019454 L-leucine Nutrition 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 description 29
- 235000001014 amino acid Nutrition 0.000 description 26
- 239000000839 emulsion Substances 0.000 description 18
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- -1 polyoxyethylene chains Polymers 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 235000015110 jellies Nutrition 0.000 description 4
- 239000008274 jelly Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- BYBBGUQRQBZUFZ-INIZCTEOSA-N dodecyl (2s)-2-amino-4-methylsulfanylbutanoate Chemical compound CCCCCCCCCCCCOC(=O)[C@@H](N)CCSC BYBBGUQRQBZUFZ-INIZCTEOSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- NQDZCRSUOVPTII-UHFFFAOYSA-N 10-methylundecan-1-ol Chemical compound CC(C)CCCCCCCCCO NQDZCRSUOVPTII-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- PCWGTDULNUVNBN-UHFFFAOYSA-N 4-methylpentan-1-ol Chemical compound CC(C)CCCO PCWGTDULNUVNBN-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101710097834 Thiol protease Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- LISDEHQPDTXACN-FQEVSTJZSA-N dodecyl (2s)-2-amino-3-phenylpropanoate Chemical compound CCCCCCCCCCCCOC(=O)[C@@H](N)CC1=CC=CC=C1 LISDEHQPDTXACN-FQEVSTJZSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Colloid Chemistry (AREA)
- Fodder In General (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Description
本発明はアミノ酸アルキルエステルと蛋白質と
の縮合物またはその塩を乳化剤として、化粧品お
よび医薬品などに有効に活用することを目的とす
るものである。
近年、乳化に関する数多くの研究がなされ、多
数の乳化剤が開発され、また乳化技術の進歩もめ
ざましく、非常に安定なエマルジヨンがあらゆる
工業で広く利用されてきている。しかし、その多
くは、ポリオキシエチレン鎖を含有する非イオン
界面活性剤、脂肪酸石けんで代表されるアニオン
界面活性剤、カチオン界面活性剤、両面界面活性
剤を乳化剤として使用しており、とくに一般消費
者の間で安全性に不安を抱くものが多い。
かかる事情に鑑み、本発明者らは人体安全性が
高いと考えられるアミノ酸アルキルエステルと蛋
白質との縮合物を乳化剤として有効に活用するた
めに鋭意研究した結果、アミノ酸アルキルエステ
ルと蛋白質との縮合物を多価アルコール中に溶解
し、これに油分を添加したならば、微細な粒子径
を持つ安定性良好なエマルジヨンを製造し得るこ
とを見いだし、本発明を完成するに至つた。
すなわち、本発明は、L−ロイシンを除くアル
キル基の炭素数が4〜12のアミノ酸アルキルエス
テルと蛋白質との縮合物および/またはその塩
と、分子内に2個以上の水酸基を有する水溶性多
価アルコールと、油分とを含有してなる乳化組成
物、およびこの乳化組成物をさらに水と混合して
得られる均一で微細な乳化粒子を有する安定な水
中油型乳化組成物を提供するものである。
本発明により得られた前記乳化組成物は透明も
しくは半透明の粘稠液体またはゲルであり、さら
に水を加えた水中油型乳化組成物は乳白色の微細
粒子のエマルジヨンである。
この微細粒子化の原因は、アミノ酸アルキルエ
ステルと蛋白質との縮合物および/またはその塩
が、多価アルコール・油界面に効果的に配向し、
相互作用をするためと考えられる。
次に本発明の構成について詳述する。
本発明において用いられる水溶性多価アルコー
ルは、分子内に水酸基を2個以上含有する水溶性
多価アルコールで、例えば、エチレングリコー
ル、プロピレングリコール、1,3−ブチレング
リコール、1,4−ブチレングリコール、ジプロ
ピレングリコール、グリセリン、及びジグリセリ
ン、トリグリセリン、テトラグリセリンなどのポ
リグリセリン、グリコース、マルトース、マルチ
トール、蔗糖、フラクトース、キシリトール、ソ
ルビトール、マルトトリオース、スレイトール、
エリスリトール、澱粉分解糖還元アルコールなど
でありこれらのうち1種または2種以上が用いら
れる。
配合量はアミノ酸アルキルエステルと蛋白質と
の縮合物および/またはその塩と、多価アルコー
ルと、油相とからなる乳化組成物の2〜95重量%
(以下、単に%と称す)である。
本発明で用いられるアミノ酸アルキルエステル
と蛋白質との縮合物は、カルボキシル基にアルキ
ル基がエステル結合したアミノ酸が、アミノ基を
介して蛋白質の遊離カルボキシル基とアミド結合
したものである。アルキル基は炭素数4〜12の飽
和、不飽和、直鎖、分岐アルキル基であり、具体
的にはブチル、ヘプチル、ヘキシル、イソヘキシ
ル、ヘキセニル、オクチル、ドデシル、イソドデ
シル基等である。又、アミノ酸はフエニルアラニ
ン、バリン、ロイシン、アラニン、イソロイシ
ン、メチオニン、セリン、リジン、トリプトフア
ン、グルタミン酸、アスパラギン酸、等のアミノ
酸であり、D−体でもL−体DL体でも構わない
が、L−ロイシンだけは本発明の範囲から除かれ
る。L−ロイシンを除く上記アミノ酸の中ではL
−体が好ましい。
上記本発明の炭素数が4〜12のアミノ酸アルキ
ルエステルと蛋白質との縮合物は例えば以下のよ
うにして得られる。
まず、アミノ酸アルキルエステルは、ブタノー
ル、ヘプタノール、ヘキサノール、ヘキセノー
ル、オクタノール、ドデカノール、イソヘキサノ
ール、イソドデカノール等の炭素数が4〜12の1
価の飽和、不飽和、直鎖、分岐アルコールとアミ
ノ酸とを四塩化炭素等の有機溶媒中で、P−トル
エンスルホン酸等を触媒として、煮沸還流し、エ
ステル結合させる。
次に、このアミノ酸アルキルエステルと蛋白質
を水溶液系で混合し、触媒として、パパイン、プ
ロメライン、フアイシンなどのチオールプロテア
ーゼを添加し、常温で反応させる。このとき蛋白
質が酵素によつて加水分解されるが、同時に加水
分解された蛋白質のC末端のカルボキシル基にア
ミノ酸アルキルエステルがアミノ基を介してアミ
ド結合し、目的のアミノ酸アルキルエステルと蛋
白質の縮合物が得られる。上記プロテアーゼによ
る加水分解およびアミド結合の反応時間や酵素の
種類を変化させることで蛋白質の分子量等は任意
に変化させることができる。
上記本発明のアミノ酸アルキルエステルと蛋白
質の縮合物を構成する蛋白質は、通常自然界より
得られる蛋白質であり、例えば、大豆蛋白、小麦
蛋白、グルテリン、ホエー粉末、大豆カゼイン、
大豆粉、フイブロイン、グルカゴン、コラーゲ
ン、ゼラチン、エラスチン、卵白リゾチーム、ア
ミラーゼ、フイブリノーゲン、ミオシン、エノラ
ーゼ、キモトリプシノーゲン、ヒストン、アクチ
ン、ケラチン、ヘモグロビン、アビジン、ペプシ
ン、グリアジン、生長ホルモン、アルブミン、グ
リブリン、ミオグロビン、カゼイン、パパイン、
β−ガラクトシダーゼ、インシユリン、リゾチー
ム、カタラーゼを挙げることができる。
前記のアミノ酸アルキルエステルと蛋白質との
縮合物を塩として使用する場合の塩を形成する物
質としては、リチウムイオン、ナトリウムイオ
ン、カリウムイオン、セシウムイオン、アンモニ
ウムイオンを含む無機、有機塩基および塩基性無
機、有機塩、アルギニン、ヒスチジン、リジン、
オルニチンなどの塩基性アミノ酸およびそれらを
残基として有する塩基性オリゴペプチド、モノエ
タノールアミン、ジエタノールアミン、トリエタ
ノールアミン、アミノ糖などの塩基性アミン等の
塩基、及び、塩酸、硫酸、硝酸、炭酸などの無機
酸、酢酸、クエン酸、マレイン酸、フマール酸な
どの有機酸、グルタミン酸、アスパラギン酸など
の酸性アミノ酸及びそれらを残基として含むオリ
ゴペプチド等の酸が用いられる。塩はあらかじめ
反応させて塩にしてから添加しても良いし、別々
に添加して、乳化組成物の製造工程中で反応させ
て塩にしてもよい。Lアミノ酸ルキルエステルと
蛋白質との縮合物の塩水溶液のPHはいくつでも構
わないが、できれば蛋白質の等電点をさけること
が好ましい。
本発明においては、上記アミノ酸アルキルエス
テルと蛋白質との縮合物およびその塩の中から任
意の1種又は2種以上を選んで用いることができ
る。
アミノ酸アルキルエステルと蛋白質との縮合物
またはその塩と、多価アルコールの配合量は、重
量比で1:1〜1000の範囲である。多価アルコー
ルの配合量がアミノ酸アルキルエステルと蛋白質
との縮合物および/またはその塩に対し1未満で
あるとアミノ酸アルキルエステルと蛋白質との縮
合物および/またはその塩の溶解性が悪くなり、
1000を超えると、乳化安定性が悪くなる。
本発明で用いられる油分は、牛脂、スクワラ
ン、オリーブ油、コメヌカ油などの動植物油脂お
よび炭化水素、流動パラフイン、ワセリンなどの
鉱物油、イソプロメピルミリステート、ペンタエ
リスリトール−テトラ−2−エチルヘキサノエー
ト、ビタミンAパルミテート、ビタミンEアセテ
ートなどのエステル油、メチルフエニルシリコ
ン、ジメチルシリコンなどのシリコン油等の、化
粧品、医薬品、食品等の業界で一般に利用される
油分である。本発明においてはこれらのうちから
1種又は2種以上が選ばれて用いられ、油分に対
し、多価アルコールと、アミノ酸アルキルエステ
ルと蛋白質と縮合物および/またはその塩との合
計量が20%以上となるように調整することが望ま
しい。
本発明に係る前記乳化組成物には前記の必須成
分の他に使用目的に合わせて、非イオン界面活性
剤、アニオン界面活性剤、カチオン界面活性剤、
両性界面活性剤、薬剤、紫外線吸収剤、防腐剤、
酸化防止剤等を混合添加しても良い。また、均質
安定化、粘度調整の目的で、アルコール、脂肪
酸、他の水溶性高分子などを添加しても良い。
本発明の乳化組成物を得るには、多価アルコー
ルまたはその水溶液中にアミノ酸アルキルエステ
ルと蛋白質との縮合および/またはその塩を溶解
し、撹拌しながら油分を添加することにより得ら
れる。この場合、ホモミキサー処理を行うことが
好ましいが、手撹拌等の弱い撹拌力でも良好な乳
化組成物を得ることができる。
ここに得られた乳化組成物は、均一で透明また
は半透明のゲルまたは粘稠な液体であるのでこの
ままで、例えば、サンケアゼリー、美容液、食用
ゼリー、薬用ゼリー、マツサージゼリー、潤滑油
などの化粧品、薬品、飼料などあらゆる分野にお
いて使用することができる。
本発明に係る水中油型乳化組成物を得るには、
前述した乳化組成物と水とを混合すれば得られ
る。この場合、ホモミキサー処理を行うことが望
ましい。ここに得られる水中油型乳化組成物は極
めて安定性に優れたものである。
水には、目的に応じて湿潤剤、水溶性ビタミ
ン、水溶性防腐剤、水溶性薬剤、水溶性高分子な
ど、化粧品、医薬品、食品などの業界で一般に汎
用される水相成分を添加することもできる。
上記乳化組成物と水との量的関係については、
極めて広範囲に選択できるが、通常乳化組成物
0.5〜80部に対して水99.5〜20部である。
ここに得られた水中油型乳化組成物は、均一な
微細粒子を分散した乳白色の粘稠あるいは低粘度
の液体であるため、このままの形態でも乳液、ク
リーム、フアウンデイシヨンなどの化粧品、シヤ
ンプー、リンスなどのトイレタリー製品、尿素ク
リーム、アクネクリームなどの医薬品、マヨネー
ズなどの食品等あらゆる分野で好適に使用するこ
とができる。また、均質安定化、粘性調整あるい
は薬効を持たせるために、他の水溶性高分子、薬
剤、界面活性剤、粉末、などを添加することも一
向に差支えない。
以下、本発明を実施例及び比較例によつてさら
に詳細に説明する。本発明はこれにより限定され
るものではない。
実施例1〜8、比較例1〜3
L−メチオニンアルキルエステルと蛋白質との
縮合物の塩、多価アルコール、精製水および油分
を表−1に示す配合組成及び量で配合し、70℃ホ
モミキサー処理して、乳化組成物を作つた。さら
に、この乳化組成物に、それに対して10倍量の水
を常温で撹拌しながら加えて、水中油型乳化組成
物を作つた。乳化組成物と水中油型乳化組成物の
状態を観察し、特性値を測定しそれらの結果を表
−1に示した。なお、各成分の数字は重量%であ
る。
The object of the present invention is to effectively utilize a condensate of an amino acid alkyl ester and a protein or a salt thereof as an emulsifier in cosmetics, medicines, and the like. In recent years, much research has been conducted on emulsification, a large number of emulsifiers have been developed, and emulsification technology has made remarkable progress, and extremely stable emulsions are now widely used in all industries. However, most of them use nonionic surfactants containing polyoxyethylene chains, anionic surfactants such as fatty acid soaps, cationic surfactants, and double-faced surfactants as emulsifiers, especially for general consumption. Many people have concerns about safety. In view of these circumstances, the present inventors conducted intensive research to effectively utilize a condensate of an amino acid alkyl ester and a protein, which is considered to be highly safe for the human body, as an emulsifier. The present inventors have discovered that it is possible to produce emulsions with fine particle size and good stability by dissolving them in polyhydric alcohol and adding an oil component thereto, leading to the completion of the present invention. That is, the present invention provides a condensate of an amino acid alkyl ester whose alkyl group has 4 to 12 carbon atoms, excluding L-leucine, and a protein and/or a salt thereof, and a water-soluble polyester having two or more hydroxyl groups in the molecule. The present invention provides an emulsified composition containing an alcohol and an oil component, and a stable oil-in-water emulsified composition having uniform and fine emulsified particles obtained by further mixing this emulsified composition with water. be. The emulsion composition obtained according to the present invention is a transparent or translucent viscous liquid or gel, and the oil-in-water emulsion composition to which water is added is an emulsion of milky white fine particles. The cause of this fine particle formation is that the condensate of amino acid alkyl ester and protein and/or its salt is effectively oriented at the polyhydric alcohol/oil interface.
This is thought to be due to interaction. Next, the configuration of the present invention will be explained in detail. The water-soluble polyhydric alcohol used in the present invention is a water-soluble polyhydric alcohol containing two or more hydroxyl groups in the molecule, such as ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol. , dipropylene glycol, glycerin, and polyglycerin such as diglycerin, triglycerin, and tetraglycerin, glycose, maltose, maltitol, sucrose, fructose, xylitol, sorbitol, maltotriose, threitol,
These include erythritol, starch-decomposing sugar-reducing alcohol, and one or more of these are used. The blending amount is 2 to 95% by weight of the emulsion composition consisting of the condensate of amino acid alkyl ester and protein and/or its salt, polyhydric alcohol, and oil phase.
(hereinafter simply referred to as %). The condensate of an amino acid alkyl ester and a protein used in the present invention is an amino acid in which an alkyl group is ester-bonded to a carboxyl group, and an amide bond is formed with a free carboxyl group of a protein via an amino group. The alkyl group is a saturated, unsaturated, linear, or branched alkyl group having 4 to 12 carbon atoms, and specifically includes butyl, heptyl, hexyl, isohexyl, hexenyl, octyl, dodecyl, isododecyl, and the like. In addition, amino acids include phenylalanine, valine, leucine, alanine, isoleucine, methionine, serine, lysine, tryptophan, glutamic acid, aspartic acid, etc., and may be in the D-form or L-form DL form, - Only leucine is excluded from the scope of the invention. Among the above amino acids except L-leucine, L
- body is preferred. The condensate of the amino acid alkyl ester having 4 to 12 carbon atoms and protein according to the present invention can be obtained, for example, as follows. First, amino acid alkyl esters include amino acid alkyl esters having 4 to 12 carbon atoms, such as butanol, heptanol, hexanol, hexenol, octanol, dodecanol, isohexanol, and isododecanol.
A saturated, unsaturated, linear, or branched alcohol and an amino acid are boiled and refluxed in an organic solvent such as carbon tetrachloride using P-toluenesulfonic acid as a catalyst to form an ester bond. Next, this amino acid alkyl ester and protein are mixed in an aqueous solution system, a thiol protease such as papain, promelain, phaicin, etc. is added as a catalyst, and the mixture is allowed to react at room temperature. At this time, the protein is hydrolyzed by the enzyme, but at the same time, the amino acid alkyl ester forms an amide bond with the C-terminal carboxyl group of the hydrolyzed protein via the amino group, resulting in a condensation of the target amino acid alkyl ester and protein. is obtained. By changing the reaction time for hydrolysis and amide bonding by the protease and the type of enzyme, the molecular weight of the protein can be arbitrarily changed. The protein constituting the condensate of amino acid alkyl ester and protein of the present invention is usually a protein obtained from nature, such as soybean protein, wheat protein, glutelin, whey powder, soybean casein,
Soy flour, fibroin, glucagon, collagen, gelatin, elastin, egg white lysozyme, amylase, fibrinogen, myosin, enolase, chymotrypsinogen, histones, actin, keratin, hemoglobin, avidin, pepsin, gliadin, growth hormone, albumin, glybulin, myoglobin, casein, papain,
Mention may be made of β-galactosidase, insulin, lysozyme and catalase. When the condensate of the amino acid alkyl ester and protein is used as a salt, the salt-forming substances include inorganic and organic bases and basic inorganic bases including lithium ions, sodium ions, potassium ions, cesium ions, and ammonium ions. , organic salts, arginine, histidine, lysine,
Basic amino acids such as ornithine, basic oligopeptides containing them as residues, bases such as basic amines such as monoethanolamine, diethanolamine, triethanolamine, and amino sugars, and hydrochloric acid, sulfuric acid, nitric acid, carbonic acid, etc. Acids such as inorganic acids, organic acids such as acetic acid, citric acid, maleic acid, and fumaric acid, acidic amino acids such as glutamic acid and aspartic acid, and oligopeptides containing these as residues are used. The salt may be reacted in advance to form a salt and then added, or may be added separately and reacted during the manufacturing process of the emulsion composition to form a salt. The pH of the aqueous salt solution of the condensate of L-amino acid alkyl ester and protein may be any value, but it is preferable to avoid the isoelectric point of the protein if possible. In the present invention, one or more of the above condensates of amino acid alkyl esters and proteins and salts thereof can be selected and used. The weight ratio of the condensate of amino acid alkyl ester and protein or its salt and polyhydric alcohol is in the range of 1:1 to 1000. If the blending amount of polyhydric alcohol is less than 1 to the condensate of amino acid alkyl ester and protein and/or its salt, the solubility of the condensate of amino acid alkyl ester and protein and/or its salt will deteriorate,
When it exceeds 1000, emulsion stability deteriorates. The oils used in the present invention include animal and vegetable oils and fats such as beef tallow, squalane, olive oil, and rice bran oil, and hydrocarbons, mineral oils such as liquid paraffin and petrolatum, isopromepyl myristate, and pentaerythritol-tetra-2-ethylhexanoate. , ester oils such as vitamin A palmitate and vitamin E acetate, and silicone oils such as methylphenyl silicone and dimethyl silicone, which are commonly used in the cosmetics, pharmaceutical, and food industries. In the present invention, one or more of these are selected and used, and the total amount of polyhydric alcohol, amino acid alkyl ester, protein, condensate and/or salt thereof is 20% of the oil content. It is desirable to adjust so that the above is achieved. In addition to the above-mentioned essential components, the emulsified composition according to the present invention may include nonionic surfactants, anionic surfactants, cationic surfactants,
Amphoteric surfactants, drugs, ultraviolet absorbers, preservatives,
Antioxidants and the like may be mixed and added. Furthermore, alcohol, fatty acids, other water-soluble polymers, etc. may be added for the purpose of homogeneity stabilization and viscosity adjustment. The emulsified composition of the present invention can be obtained by dissolving the condensation of amino acid alkyl ester and protein and/or its salt in a polyhydric alcohol or an aqueous solution thereof, and adding an oil component while stirring. In this case, it is preferable to perform a homomixer treatment, but a good emulsified composition can be obtained even with a weak stirring force such as manual stirring. The emulsified composition obtained here is a uniform, transparent or translucent gel or viscous liquid, so it can be used as it is, for example, in sun care jelly, beauty serum, edible jelly, medicinal jelly, pine surge jelly, lubricating oil, etc. It can be used in all fields such as cosmetics, medicine, and feed. To obtain the oil-in-water emulsion composition according to the present invention,
It can be obtained by mixing the emulsified composition described above and water. In this case, it is desirable to perform homomixer treatment. The oil-in-water emulsion composition obtained here has extremely excellent stability. Depending on the purpose, water phase components commonly used in the cosmetics, pharmaceutical, food, and other industries may be added to the water, such as humectants, water-soluble vitamins, water-soluble preservatives, water-soluble drugs, and water-soluble polymers. You can also do it. Regarding the quantitative relationship between the above emulsified composition and water,
Although there is a very wide range of choice, usually emulsified compositions
0.5 to 80 parts to 99.5 to 20 parts of water. The oil-in-water emulsion composition obtained here is a milky white viscous or low viscosity liquid in which uniform fine particles are dispersed, so it can be used in cosmetics such as emulsions, creams, foundations, and shampoos even in its original form. It can be suitably used in all fields such as toiletry products such as rinses, pharmaceuticals such as urea cream and acne cream, and foods such as mayonnaise. Furthermore, there is no problem in adding other water-soluble polymers, drugs, surfactants, powders, etc. in order to stabilize homogeneity, adjust viscosity, or impart medicinal effects. Hereinafter, the present invention will be explained in more detail with reference to Examples and Comparative Examples. The present invention is not limited thereby. Examples 1 to 8, Comparative Examples 1 to 3 A salt of a condensate of L-methionine alkyl ester and a protein, a polyhydric alcohol, purified water, and an oil component were blended in the composition and amounts shown in Table 1, and the mixture was heated at 70°C. An emulsion composition was prepared by processing with a mixer. Furthermore, an oil-in-water emulsion composition was prepared by adding 10 times the amount of water to this emulsion composition while stirring at room temperature. The states of the emulsified composition and oil-in-water emulsified composition were observed, and their characteristic values were measured, and the results are shown in Table 1. Note that the numbers for each component are weight %.
【表】【table】
【表】
表−1に示したように、L−メチオニンアルキ
ルエステルと蛋白質との縮合物の塩を含まない組
成(比較例1)、および多価アルコールを含まず、
水を外相とした組成(比較例2)では、安定な乳
化組成物は得られなかつた。さらに、L−メチオ
ニンアルキルエステルと蛋白質との縮合物の塩、
多価アルコールおよび油を含んでも、多価アルコ
ールが相対的に少ない(比較例3)と、安定な乳
化組成物は得られなかつた。これに対して、本発
明に係る実施例1〜8については、いずれの水準
においても非常に良好な透明あるいは半透明の粘
稠な液体またはゲルが得られ、さらに、水を加え
て得られた水中油型乳化組成物は、非常に微細な
粒子の分散した安定なエマルジヨンであつた。
実施例 9
水性化粧用油 (重量%)
(A) L−フエニルアラニンドデシル
エステルゼラチン縮合物
アルギニン塩 2.0
マルチトール(70%水溶液) 30.0
1,3−ブチレングリコール 10.0
コンドロイチン硫酸ナトリウム 0.5
(B) 流動パラフイン 30.0
オリーブ油 20.8
グリセリルトリステアレート 5.0
ビタミンEアセテート 0.5
ビタミンAパルミテート 0.5
防腐剤 0.5
香 料 0.2
(A)相を70℃で十分撹拌し、(B)相を70℃で溶解し
たものを(A)相に撹拌しながら添加した。このもの
をホモミキサー処理し、撹拌冷却して水性化粧用
油を得た。この化粧用油は、粘稠でやや流動感の
ある透明ゲル状を呈し、皮膚安全性が高く、かつ
経時安定性の優れた乳化物で、皮膚に塗布したと
き、非常にのびが良く、少量にて広範囲に拡がる
使用特性を有していた。
実施例 10
(重量%)
(A) 局方グリセリン 20.0
1,3−ブチレングリコール 5.0
L−メチオニンドデシルエステル
エラスチン縮合物 2.0
L−メチオニンヘキセニルエステル
グロブリン縮合物 1.0
アラントイン 0.2
水酸化ナトリウム 0.1
(B) 流動パラフイン 10.0
オリーブ油 5.0
ペンタエリスリトールーテトラー
2−エチルヘキサノエート 5.0
ワセリン 5.0
エチニルエストラジオール 0.1
防腐剤 0.4
香料 0.3
(C) 精製水 45.5
アルギン酸ナトリウム 0.1
キサンテンガム 0.1
キズナ抽出液 0.1
センブリ抽出液 0.1
実施例9の製造法に準じて、(A)相(B)相より乳化
組成物を得、70℃とし、別に調整し70℃に保つて
おいた増粘剤水溶液(C)相で希釈分散した後、冷却
し水中油型エマルジヨンの栄養乳液を得た。この
乳液の粘度は30℃で、4280cpであり、乳化粒子
径1〜3μ程度の安定でかつなじみの良い感触を
有していた。
実施例 11
サンケアクリーム (重量%)
(A) ジグセリン 20.0
ソルビトール(70%水溶液) 8.0
ブドウ糖(50%水溶液) 4.0
L−メチオニンドデシル
エステル牛乳蛋白縮合物の塩酸塩 2.0
L−メチオニンドデシル
エステルアルブミン縮合物 0.5
(B) 流動パラフイン 20.0
イソプロピルミリステート 10.0
ワセリン 5.0
ステアリルアルコール 5.0
PABA 2.0
防腐剤 0.5
香 料 0.3
(C) 精製水 19.5
ヒドロキシエチルセルロース 0.2
(D) 調合粉末 1.0
二酸化チタン 2.0
実施例10の製造法に準じて、サンケアクリーム
を得た。このとき、(C)相は(D)を70℃にて分散ホモ
ミキサー処理した後、希釈相として使用した。こ
のサンケアクリームは、25℃で硬度が17であり、
やや透明感があり、また乳化粒子径が1〜3μ程
度で安定性の良い水中油型乳化組成物で、太陽光
の下で好適に使用できるものであつた。[Table] As shown in Table 1, a composition containing no salt of the condensate of L-methionine alkyl ester and protein (Comparative Example 1), and a composition containing no polyhydric alcohol,
A stable emulsified composition could not be obtained with the composition in which water was used as an external phase (Comparative Example 2). Furthermore, a salt of a condensate of L-methionine alkyl ester and protein,
Even if polyhydric alcohol and oil were included, a stable emulsified composition could not be obtained when the polyhydric alcohol was relatively small (Comparative Example 3). On the other hand, in Examples 1 to 8 according to the present invention, very good transparent or translucent viscous liquids or gels were obtained at all levels, and furthermore, they were obtained by adding water. The oil-in-water emulsion composition was a stable emulsion with very fine particles dispersed therein. Example 9 Aqueous cosmetic oil (% by weight) (A) L-phenylalanine dodecyl ester gelatin condensate Arginine salt 2.0 Maltitol (70% aqueous solution) 30.0 1,3-butylene glycol 10.0 Sodium chondroitin sulfate 0.5 (B) Fluidity Paraffin 30.0 Olive oil 20.8 Glyceryl tristearate 5.0 Vitamin E acetate 0.5 Vitamin A palmitate 0.5 Preservatives 0.5 Flavor 0.2 Stir the (A) phase thoroughly at 70℃, dissolve the (B) phase at 70℃, and make (A) Added to the phase with stirring. This product was treated with a homomixer, stirred and cooled to obtain an aqueous cosmetic oil. This cosmetic oil is a viscous, slightly fluid, transparent gel-like emulsion that is highly safe for the skin and has excellent stability over time.When applied to the skin, it spreads very easily and in small amounts. It had a wide range of usage characteristics. Example 10 (% by weight) (A) Pharmacopoeia glycerin 20.0 1,3-butylene glycol 5.0 L-methionine dodecyl ester Elastin condensate 2.0 L-methionine hexenyl ester Globulin condensate 1.0 Allantoin 0.2 Sodium hydroxide 0.1 (B) Liquid paraffin 10.0 olive oil 5.0 Penta Eli Slitrito Lutetler 2 -Ethyl Hexano Eates 5.0 Vaseline 5.0 Ethinyl Estrad Earlen 0.4 Pillar 0.3 fragrance 0.3 (C) Purified Water 0.1 Kisuna Tengam 0.1 Kizuna Tengam 0.1 Kizuna extract 0.1 Sembrid extraction 0.1 Production of Example 9 According to the method, an emulsion composition was obtained from phase (A) and (B), heated to 70℃, diluted and dispersed with a thickener aqueous solution (C) phase prepared separately and kept at 70℃, and then cooled. A nutritional emulsion of oil-in-water emulsion was obtained. The viscosity of this emulsion was 4280 cp at 30°C, and the emulsion had a stable emulsion particle size of about 1 to 3 μm and a familiar texture. Example 11 Suncare cream (% by weight) (A) Digcerin 20.0 Sorbitol (70% aqueous solution) 8.0 Glucose (50% aqueous solution) 4.0 L-methionine dodecyl ester milk protein condensate hydrochloride 2.0 L-methionine dodecyl ester albumin condensate 0.5 (B) Liquid paraffin 20.0 Isopropyl myristate 10.0 Vaseline 5.0 Stearyl alcohol 5.0 PABA 2.0 Preservative 0.5 Fragrance 0.3 (C) Purified water 19.5 Hydroxyethylcellulose 0.2 (D) Mixed powder 1.0 Titanium dioxide 2.0 According to the manufacturing method of Example 10 , got the sun care cream. At this time, phase (C) was used as a diluted phase after treating (D) with a dispersion homomixer at 70°C. This sun care cream has a hardness of 17 at 25℃.
The oil-in-water emulsion composition was somewhat transparent and had a highly stable emulsion particle size of about 1 to 3 microns, making it suitable for use under sunlight.
Claims (1)
〜12のアミノ酸アルキルエステルと蛋白質との縮
合物および/またはその塩と、分子内に2個以上
の水酸基を有する水溶性多価アルコールと、油分
とを含有することを特徴とする乳化組成物。 2 L−ロイシンを除くアルキル基の炭素数が4
〜12のアミノ酸アルキルエステルと蛋白質との縮
合物および/またはその塩と、分子内に2個以上
の水酸基を有する水溶性多価アルコールと、油分
とを含む乳化組成物と、水とを含有することを特
徴とする水中油型乳化組成物。[Claims] 1 The number of carbon atoms in the alkyl group excluding L-leucine is 4
An emulsified composition comprising a condensate of ~12 amino acid alkyl esters and a protein and/or a salt thereof, a water-soluble polyhydric alcohol having two or more hydroxyl groups in the molecule, and an oil component. 2 The number of carbon atoms in the alkyl group excluding L-leucine is 4
An emulsified composition containing a condensate of ~12 amino acid alkyl esters and a protein and/or a salt thereof, a water-soluble polyhydric alcohol having two or more hydroxyl groups in the molecule, an oil component, and water. An oil-in-water emulsion composition characterized by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58205527A JPS6097042A (en) | 1983-11-01 | 1983-11-01 | Emulsified composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58205527A JPS6097042A (en) | 1983-11-01 | 1983-11-01 | Emulsified composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6097042A JPS6097042A (en) | 1985-05-30 |
| JPH0359735B2 true JPH0359735B2 (en) | 1991-09-11 |
Family
ID=16508358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58205527A Granted JPS6097042A (en) | 1983-11-01 | 1983-11-01 | Emulsified composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6097042A (en) |
-
1983
- 1983-11-01 JP JP58205527A patent/JPS6097042A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6097042A (en) | 1985-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH057061B2 (en) | ||
| KR102292009B1 (en) | Dispersion liquid and method for forming hydrogel | |
| JPH0230733B2 (en) | ||
| TW200812635A (en) | Emulsion composition | |
| US4963656A (en) | Emulsified compositions containing elastin hydrolysate | |
| JPH0356777B2 (en) | ||
| JP3454385B2 (en) | Method for producing O / W type skin cream | |
| JPH0359736B2 (en) | ||
| JPH0435212B2 (en) | ||
| JPH0364185B2 (en) | ||
| JPS5998727A (en) | Emulsified composition | |
| JPH045489B2 (en) | ||
| JPS5920212A (en) | Emulsified composition | |
| JPH0359735B2 (en) | ||
| JPS60244335A (en) | Emulsified composition | |
| JPS5926130A (en) | Emulsion composition | |
| JPH0720543B2 (en) | Method for producing gel emulsion and oil-in-water emulsion | |
| JPH0438448B2 (en) | ||
| US20210145706A1 (en) | Cosmetic | |
| WO2007003658A1 (en) | Composition in the form of a lipogel for cosmetic, cleansing and pharmaceutical use | |
| JPS61129038A (en) | Emulsifier composition | |
| JPH045490B2 (en) | ||
| JPH0930928A (en) | Skin cosmetic containing whey (lactoskin) consisting of specific ingredients | |
| JPS59173124A (en) | Emulsified composition | |
| JPS6369536A (en) | emulsifying composition |